The announcement comes after a federal judge ruled Sept. 28 that HHS must immediately cover 340B drug costs rather than wait until 2023.
HHS said Sept. 30 it needed two weeks to put a plan in place because required “revisions to four different electronic data files and then testing by multiple offices to confirm that the revised files function appropriately before the files are loaded to the production environment where they will be used to calculate OPPS reimbursements on a prospective basis.”
In June, the Supreme Court ruled in favor of hospitals on part of the 340B program — which allows eligible hospitals to buy discounted outpatient drugs — and said HHS could not vary the program’s reimbursement, which it did in 2018 by lowering it by 28.5 percent and then later to 22.5 percent.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.